Medical AI Co., Ltd.

Medical AI Co., Ltd. specializes in AI-driven diagnostic devices for cardiology. Their portfolio includes tools like the AiTiALVDD, which assesses left ventricular diastolic dysfunction, the AiTiAMI for detecting atrial myocardial infarction, and the AiTiALVSD for evaluating left ventricular systolic dysfunction. These devices use AI algorithms to analyze medical imaging data to assist in automated diagnostic support.

Medical AI Co., Ltd. is headquartered in South Korea. The company’s location in South Korea positions it to serve global markets while leveraging regional expertise in medical technology development.

Medical AI Co., Ltd.’s devices are registered in the eudamed database, which is the European Union’s central registry for medical devices. This inclusion ensures transparency and compliance with EU regulatory requirements for Class IIa devices.

Medical AI Co., Ltd.’s devices fall under Class IIa classification in the EU. This classification is determined based on the risk associated with the device’s intended purpose and design, with Class IIa representing moderate-risk devices requiring additional scrutiny to ensure safety and performance.